Title |
The MGuard coronary stent: safety, efficacy, and clinical utility
|
---|---|
Published in |
Vascular Health and Risk Management, September 2015
|
DOI | 10.2147/vhrm.s68007 |
Pubmed ID | |
Authors |
Montserrat Gracida, Rafael Romaguera, Francisco Jacobi, Joan A Gómez-Hospital, Angel Cequier |
Abstract |
Atheromatous and thrombotic embolization during percutaneous coronary revascularization is a feared complication that may cause impaired myocardial reperfusion even with a patent epicardial vessel. The MGuard stent is a cobalt chromium bare metal stent with a porous net attached to its outer surface that has been designed to prevent thrombus fragmentation and distal embolization during stent implantation. This review summarizes the available evidence supporting the use of the MGuard stent in different scenarios such as lesions with high thrombus burden, saphenous vein graft interventions, coronary perforations, or carotid lesions. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Brazil | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 1 | 4% |
Austria | 1 | 4% |
Unknown | 25 | 93% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 4 | 15% |
Researcher | 4 | 15% |
Student > Ph. D. Student | 3 | 11% |
Student > Doctoral Student | 2 | 7% |
Student > Bachelor | 1 | 4% |
Other | 3 | 11% |
Unknown | 10 | 37% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 13 | 48% |
Biochemistry, Genetics and Molecular Biology | 1 | 4% |
Psychology | 1 | 4% |
Business, Management and Accounting | 1 | 4% |
Social Sciences | 1 | 4% |
Other | 1 | 4% |
Unknown | 9 | 33% |